See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Carcinogens in lung tissue from smokers (closed to entry as of 7/15/07) and non-smokers with newly diagnosed Stage I, Stage II, or Stage III non-small cell lung cancer
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-dde0-d6ca-9953-50a980000000
Resource Type
Properties
-
-
ClinicalTrials.gov url
-
http://www.clinicaltrials.gov/ct2/show/NCT00450281?term=S0424&rank=1
-
-
Observational Method
-
gene expression analysis
-
-
Observational Method
-
PCR
-
-
Observational Method
-
chromogenic in situ hybridization
-
-
Observational Method
-
mutation analysis
-
-
Observational Method
-
biomarker analysis
-
-
Additional Topic(s)
-
carcinogens
-
-
Additional Topic(s)
-
non-smokers
-
-
Additional Topic(s)
-
smokers
-
-
Resource Description
-
This clinical trial is studying carcinogens in lung tissue from smokers (closed to entry as of 7/15/07) and non-smokers with newly diagnosed stage I, stage II, or stage III non-small cell lung cancer.
-
-
Additional Name
-
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
-
-
Contact
-
Berenberg, Jeffrey
-
-
PI
-
Berenberg, Jeffrey
-
-
Topic
-
non-small cell lung carcinoma
-
-
Study Population
-
900 men and women 18 years and older with newly diagnosed non-small-cell lung cancer and meeting other therapeutic and disease-related criteria
-
-
Funded by
-
SWOG
-
-
Phase
-
Phase 3 clinical trial
-
-
Performed by
-
Clinical Protocol & Data Management Shared Resource
